Sign in

CIK 0001933414

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
841966887
Phone
+1 888-378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-09 AKKARAJU SRINIVAS Director Grant or award · Stock Option +44,000 44,000
2023-02-09 Asam Alexander Director Grant or award · Stock Option +44,000 44,000
2023-02-09 Congleton Jon Chief Executive Officer Grant or award · Stock Option +250,046 250,046
2023-02-09 Levy Adam Scott CFO, Chief Bus. Off. and Secy. Grant or award · Stock Option +97,518 97,518
2023-02-09 Rodman David Malcom Chief Medical Officer Grant or award · Stock Option +104,186 104,186
2023-02-09 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option +44,000 44,000

Page 23 of 23 · 446 trades